Monsenso AS Total Liabilities

Latest as of June 2026: Dkr4.08 Million DKK ≈ $638.19K USD

Monsenso AS total liabilities. Based on the latest financial reports, Monsenso AS (MONSO) has total liabilities worth Dkr4.08 Million DKK (≈ $638.19K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Monsenso AS defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Monsenso AS (2015–2025)

Total liabilities of Monsenso AS from 2015 to 2025. This chart illustrates how Monsenso AS's total liabilities have evolved over time, based on quarterly financial data.

Monsenso AS Competitors by Total Liabilities

The table below lists competitors of Monsenso AS ranked by their total liabilities.

Company Country Total Liabilities
H3 Energy Limited
AU:H3E
Australia AU$4.89 Million
American Rebel Holdings Inc
NASDAQ:AREB
USA $24.12 Million
Techfast Holdings Bhd
KLSE:0084
Malaysia RM5.07 Million
BuilderSmart Public Company Limited
BK:BSM
Thailand ฿737.57 Million
Mesa Royalty Trust
NYSE:MTR
USA $180.62K
Spineway
PA:ALSPW
France €6.40 Million
FW Thorpe PLC
LSE:TFW
UK GBX46.27 Million
E-Home Household Service Holdings Ltd
NASDAQ:EJH
USA $10.27 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Monsenso AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see MONSO total asset value.

Liquidity & Leverage Metrics

Monsenso AS Total Liabilities Ratios Explained

Monsenso AS total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.15 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.61 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.38 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Monsenso AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Monsenso AS (2015–2025)

The table below shows the annual total liabilities of Monsenso AS from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 Dkr6.07 Million
≈ $950.32K
+40.41%
2024-12-31 Dkr4.33 Million
≈ $676.83K
-46.01%
2023-12-31 Dkr8.01 Million
≈ $1.25 Million
+94.63%
2022-12-31 Dkr4.12 Million
≈ $644.13K
-26.63%
2021-12-31 Dkr5.61 Million
≈ $877.88K
-43.61%
2020-12-31 Dkr9.95 Million
≈ $1.56 Million
+30.83%
2019-12-31 Dkr7.61 Million
≈ $1.19 Million
-19.10%
2018-12-31 Dkr9.40 Million
≈ $1.47 Million
-16.41%
2017-12-31 Dkr11.25 Million
≈ $1.76 Million
+167.14%
2016-12-31 Dkr4.21 Million
≈ $658.65K
-5.36%
2015-12-31 Dkr4.45 Million
≈ $695.99K
--

About Monsenso AS

CO:MONSO Denmark Health Information Services
Market Cap
$3.78 Million
Dkr24.19 Million DKK
Market Cap Rank
#29063 Global
#140 in Denmark
Share Price
Dkr0.25
Change (1 day)
+19.05%
52-Week Range
Dkr0.10 - Dkr0.48
All Time High
Dkr23.50
About

Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes. It also provides Monsenso solution,… Read more